Vir Biotechnology, Inc. (90) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Stock Purchase Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
(Filed With SEC on February 28, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on July 6, 2020)
-
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 29, 2017
(Filed With SEC on September 3, 2019)
-
Amended and Restated Warrant, issued to Takeda Ventures, Inc
(Filed With SEC on September 3, 2019)
-
Securities Purchase Agreement between the Registrant, Humabs BioMed SA, the shareholders of Humabs set forth therein, the option-holders of Humabs set forth therein and Fortis...
(Filed With SEC on September 3, 2019)
-
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021
(Filed With SEC on May 6, 2021)
-
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020
(Filed With SEC on July 6, 2020)
-
Description of Capital Stock
(Filed With SEC on March 26, 2020)
-
Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019
(Filed With SEC on March 26, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 30, 2019)
-
Form of Common Stock Certificate of the Registrant
(Filed With SEC on September 30, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on September 30, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on September 3, 2019)
-
Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017
(Filed With SEC on September 3, 2019)